Liminatus Pharma, Inc. Class A Common Stock (LIMN)
LIMN Stock Price Chart
Explore Liminatus Pharma, Inc. Class A Common Stock interactive price chart. Choose custom timeframes to analyze LIMN price movements and trends.
LIMN Company Profile
Discover essential business fundamentals and corporate details for Liminatus Pharma, Inc. Class A Common Stock (LIMN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 May 2025
Employees
3.00
Website
https://liminatuspharma.comCEO
Chris Kim
Description
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
LIMN Financial Timeline
Browse a chronological timeline of Liminatus Pharma, Inc. Class A Common Stock corporate events including earnings releases, dividend announcements, and stock splits.
LIMN Stock Performance
Access detailed LIMN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.